Novel 3-Amino-6-chloro-7-(azol-2 or 5-yl)-1,1-dioxo-1,4,2-benzodithiazine Derivatives with Anticancer Activity: Synthesis and QSAR Study

A series of new 3-amino-6-chloro-7-(azol-2 or 5-yl)-1,1-dioxo-1,4,2-benzodithiazine derivatives 5a–j have been synthesized and evaluated in vitro for their antiproliferative activity at the U.S. National Cancer Institute. The most active compound 5h showed significant cytotoxic effects against ovarian (OVCAR-3) and breast (MDA-MB-468) cancer (10% and 47% cancer cell death, respectively) as well as a good selectivity toward prostate (DU-145), colon (SW-620) and renal (TK-10) cancer cell lines. To obtain a deeper insight into the structure-activity relationships of the new compounds 5a–j QSAR studies have been applied. Theoretical calculations allowed the identification of molecular descriptors belonging to the RDF (RDF055p and RDF145m in the MOLT-4 and UO-31 QSAR models, respectively) and 3D-MorSE (Mor32m and Mor16e for MOLT-4 and UO-31 QSAR models) descriptor classes. Based on these data, QSAR models with good robustness and predictive ability have been obtained.

[1]  F. Sa̧czewski,et al.  Synthesis, structural characterization and in vitro antitumor activity of 4-dimethylaminopyridinium (6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)methanides. , 2003, European journal of medicinal chemistry.

[2]  P. Bednarski,et al.  Synthesis, structural characterization, and in vitro antitumor activity of novel N-(6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)arylsulfonamides. , 2007, Bioorganic & medicinal chemistry.

[3]  J. Sławiński,et al.  Synthesis and Antitumor Activity of Novel N′-(2-Benzylthiobenzenesulfonyl)-1H-pyrazole-1-amidine Derivatives. , 2011 .

[4]  Synthesis, antitumor and anti-HIV activities of benzodithiazine-dioxides. , 2006, Bioorganic & medicinal chemistry.

[5]  M. Gdaniec,et al.  Synthesis and anticancer activity of 2-amino-8-chloro-5,5-dioxo[1,2,4]triazolo[2,3-b][1,4,2]benzodithiazine derivatives. , 2003, Bioorganic & medicinal chemistry.

[6]  D A Scudiero,et al.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. , 1988, Cancer research.

[7]  J. Sławiński,et al.  [1,1-dioxo-1,4,2-benzodithiazine derivatives. I. Synthesis of various 7-carboxy-3-mercapto-1,1-dioxo-1,4,2-benzodithiazine]. , 1984, Acta poloniae pharmaceutica.

[8]  N. Neamati,et al.  Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines. , 2004, Bioorganic & medicinal chemistry.

[9]  M R Grever,et al.  The National Cancer Institute: cancer drug discovery and development program. , 1992, Seminars in oncology.

[10]  F. Sa̧czewski,et al.  Synthesis, structural characterization and in vitro antitumor activity of novel 6-chloro-1,1-dioxo-1,4,2-benzodithiazie derivatives. , 2003, Bioorganic & medicinal chemistry.

[11]  P. Bednarski,et al.  Synthesis, Cytotoxicity Testing, and Structure–Activity Relationships of Novel 6‐Chloro‐7‐(4‐phenylimino‐4H‐3,1‐benzoxazin‐2‐yl)‐3‐(substituted)‐1,4,2‐benzodithiazine 1,1‐dioxides , 2011, Archiv der Pharmazie.

[12]  F. Sa̧czewski,et al.  A new type of mixed anhydride and its applications to the synthesis of 7-substituted 8-chloro-5,5-dioxoimidazo[1,2-b][1,4,2]benzodithiazines with in vitro antitumor activity. , 2002, Journal of medicinal chemistry.

[13]  Synthesis and QSAR Study of Novel 6-Chloro-3-(2-Arylmethylene-1-methylhydrazino)-1,4,2-benzodithiazine 1,1-Dioxide Derivatives with Anticancer Activity , 2015, Molecules.

[14]  M. Boyd,et al.  Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen , 1995 .

[15]  R. Shoemaker.  The NCI60 human tumour cell line anticancer drug screen , 2006, Nature Reviews Cancer.

[16]  J. Sławiński,et al.  1-(2-Mercaptobenzenesulfonyl)-3-hydroxyguanidines--novel potent antiproliferatives, synthesis and in vitro biological activity. , 2012, European journal of medicinal chemistry.